Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG33837

ANO10 Knockout jurkat Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Blood (peripheral blood)

  • Disease:

    Acute lymphoblastic leukemia (ALL)

The ANO10 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from human Jurkat T lymphocytes, engineered to disrupt the ANO10 gene. ANO10 encodes a calcium-activated chloride channel and phospholipid scramblase that is activated by intracellular Ca2+, calmodulin, and PIP2, mediating chloride efflux and phosphatidylserine externalization. This knockout model abrogates ANO10 function, enabling study of its roles in T-cell receptor signaling, ion homeostasis, and membrane lipid asymmetry. Applications include investigation of calcium-activated chloride channel biology, phospholipid scrambling mechanisms, and drug screening for ANO10 modulators, with relevance to spinocerebellar ataxia type 10 (SCAR10) and cerebellar atrophy. Key assays such as Annexin V staining, chloride-sensitive dyes, and electrophysiology can be applied to these cells.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Jurkat

    Cell Type

    T cell line

    Sex of Donor

    Male

    Age

    14 years

    Derived From Site

    In situ; Peripheral blood

    Gene Name

    ANO10

    Gene Identifier

    NCBI Gene ID 55129

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ANO10 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population originating from the human Jurkat T lymphocyte line, created to disrupt the ANO10 gene and eliminate its chloride channel and scramblase functions. This genetically heterogeneous pool provides a robust loss-of-function platform for dissecting ANO10-mediated ion and lipid dynamics in T-cell receptor signaling contexts. These cells serve as a powerful tool for exploring the downstream consequences of ANO10 ablation in immune cell signaling.

The Jurkat cell line, an immortalized human T lymphocyte derived from acute T cell leukemia, is a canonical model for T-cell receptor signaling, calcium mobilization, and immune response studies. Its acute leukemia origin endows it with robust proliferative capacity and well-defined signaling cascades, including stimulus-induced intracellular Ca2+ elevation that directly activates ANO10. The Jurkat background thus permits investigation of how ANO10-mediated chloride flux and phospholipid scrambling intersect with T-cell activation pathways, cytokine production, and membrane dynamics.

ANO10 encodes a dual-function protein that acts both as a calcium-activated chloride channel and a phospholipid scramblase. Activation is triggered by intracellular Ca2+ elevation, often downstream of GPCR-mediated IP3 production and CaMKII-mediated phosphorylation, and requires PIP2 binding. Upon activation, ANO10 binds calmodulin and facilitates chloride efflux and phosphatidylserine externalization, modulating membrane potential and cell volume while altering membrane lipid asymmetry. ERM proteins??ezrin, radixin, and moesin??interact with ANO10, anchoring it to the cytoskeleton and regulating its spatial activity. Collectively, these interactions position ANO10 as an integrator of calcium signals into ion and lipid fluxes critical for cellular homeostasis.

Disruption of ANO10 in Jurkat cells using CRISPR/Cas9 generates a polyclonal population lacking functional channel and scramblase activities, offering a direct means to assess ANO10-dependent processes. Loss of ANO10 abrogates Ca2+-induced phosphatidylserine exposure, quantifiable by Annexin V flow cytometry, and eliminates Ca2+-activated chloride currents, measurable by chloride-sensitive fluorescent dyes or patch clamp electrophysiology. This knockout model also enables examination of associated changes in cell volume regulation and membrane potential, which are essential for normal T-cell responses such as immunological synapse formation and activation-induced cell swelling.

Research applications for these polyclonal knockout cells span functional studies of calcium-activated chloride channels, dissection of phospholipid signaling networks in T cells, drug screening for ANO10 inhibitors or activators, and exploration of pathogenic mechanisms underlying spinocerebellar ataxia type 10 (SCAR10) and cerebellar atrophy. Typical experiments integrate calcium flux assays, phospholipid scrambling probes, and immunoblotting for ANO10 to validate knockdown and downstream signaling effects. For additional technical information or to inquire about custom reagents, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)